LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Legal & Regulatory and Reimbursement/Hospitals Settle Kyphoplasty False Claims for $34 Million
Legal & Regulatory and Reimbursement

Hospitals Settle Kyphoplasty False Claims for $34 Million

July 3, 2013 2 min read Premium comments

Advertisement

Hospitals Settle Kyphoplasty False Claims for $34 Million
Image created by RRY Publications, LLC. / Source: Morguefile
Secondary

Fifty-five hospitals in 21 states will pay the government more than $34 million for allegedly cheating Medicare over kyphoplasty procedures.

The Justice Department announced on July 2, 2013, that the hospitals improperly billed Medicare by keeping patients overnight for Medtronic Inc.’s outpatient kyphoplasty spine procedure. Kyphoplasty, according to the government, can be performed safely and effectively as an outpatient procedure without any need for a more costly hospital admission.

“Hospitals that participate in the Medicare program must bill for their services accurately and honestly, ” said Stuart F. Delery, Acting Assistant Attorney General for the Civil Division of the Department of Justice.  “The Department of Justice is committed to ensuring that Medicare funds are expended appropriately, based on the medical needs of patients rather than the desire of medical providers to maximize profits.”

$75 Million Collected So Far

More than 100 hospitals have paid approximately $75 million to resolve allegations that they mischarged Medicare for kyphoplasty procedures. The government previously settled with Medtronic Spine LLC, the corporate successor to Kyphon Inc., for $75 million to settle allegations that the company defrauded Medicare by counseling hospital providers to perform kyphoplasty procedures as inpatient rather than outpatient procedures.

The largest payment of $7.1 million will be paid by 23 hospitals affiliated with the HCA Inc., of Nashville, Tennessee. The single biggest settlement by one hospital was $4.2 million by the Atrium Medical Center in Middletown, Ohio. Five hospitals affiliated with Trinity Health, Livonia, Michigan, have agreed to pay a total of $3.9 million. Four hospitals affiliated with Morton Plant Mease BayCare Health System, Clearwater, Florida, agreed to pay a total of $2.3 million. The rest were for less than $2 million.

Whistleblowers Collect $5.5 Million

All but four of the settling facilities announced on July 2, were named as defendants in a whistleblower lawsuit brought under the False Claims Act. The lawsuit was filed in federal district court in Buffalo, New York, by Craig Patrick and Charles Bates. Patrick is a former reimbursement manager for Kyphon, and Bates was formerly a regional sales manager for Kyphon in Birmingham, Alabama. They will receive a total of approximately $5.5 million from the announced settlements.

Advertisement

Medtronic paid over $4 billion for Kyphon in 2007. The company recently sold over 500 of the kyphoplasty patents to Orthophoenix LLC of Dallas, Texas.

The Justice Department says the agency has used the False Claims Act to recover more than $10.7 billion since January 2009 in cases involving fraud against federal health care programs. The government’s total recoveries in False Claims Act cases since January 2009 are over $14.7 billion.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy